MIRA Pharmaceuticals Future Growth
Future criteria checks 0/6
MIRA Pharmaceuticals is forecast to grow earnings and revenue by 14.4% and 86.4% per annum respectively while EPS is expected to grow by 8.3% per annum.
Key information
14.4%
Earnings growth rate
8.3%
EPS growth rate
| Pharmaceuticals earnings growth | 17.9% |
| Revenue growth rate | 86.4% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 30 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 276 | -9 | 396 | N/A | 2 |
| 12/31/2025 | N/A | -10 | -14 | -8 | 3 |
| 12/31/2024 | N/A | -8 | -3 | -6 | 3 |
| 6/30/2024 | N/A | -13 | -5 | -5 | N/A |
| 3/31/2024 | N/A | -12 | -5 | -5 | N/A |
| 12/31/2023 | N/A | -12 | -5 | -5 | N/A |
| 9/30/2023 | N/A | -8 | -4 | -4 | N/A |
| 6/30/2023 | N/A | -6 | -4 | -4 | N/A |
| 3/31/2023 | N/A | -7 | -5 | -5 | N/A |
| 12/31/2022 | N/A | -7 | -6 | -6 | N/A |
| 3/31/2022 | N/A | -4 | -3 | -3 | N/A |
| 12/31/2021 | N/A | -2 | -1 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: K6S is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: K6S is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: K6S is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: K6S is forecast to have no revenue next year.
High Growth Revenue: K6S is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if K6S's Return on Equity is forecast to be high in 3 years time